Mechanistically, our study demonstrated that SFRP1-producing CAFs interact with cancer cells via the SFRP1-FGFR2-HIF1 signaling axis to drive both tumor stemness and metastatic potential. The gene discussed is HIF1A; the disease is neoplasm.